MYCN and neuroblastoma: Here, we present long-term outcomes of the Austrian neuroblastoma trial A-NB94, initiated in 1994 to apply a risk-adapted strategy of treatment (RAST) based on age (≤/>12 months), INSS stage and MYCN Status (Table 1).